ABSTRACT -This study evaluated the anti-apoptotic activity of fucoxanthin in carbon tetrachloride (CCl 4 )-induced hepatotoxicity. An in vitro study using the 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) assay clearly demonstrated an attenuation of CCl 4 -induced hepatotoxicity with fucoxanthin. This effect was dose-dependent; 25 μM was more effective than 10 μM of fucoxanthin for attenuating the hepatotoxicity induced by 5 mM of CCl 4 . Acute CCl 4 -hepatotoxicity in rats, with numerous cells positive for the terminal deoxynucleotidyl -transferase (TdT) -mediated deoxyuridine triphosphatedigoxigenin (dUTP) nick-end labeling (TUNEL) stain were seen in the pericentral area of the hepatic lobule. Oral pretreatment of CCl 4 -injected rats with fucoxanthin significantly reduced hepatocyte apoptosis. Fucoxanthin was immunohistochemically shown to increase heme oxygenase-1 expression in the cultured liver cells of Hc cells and TRL1215 cells. By oral pretreatment of CCl 4 -injected rats with fucoxanthin, the hepatic heme oxygenase-1 protein levels were significantly increased compared to those not pretreated with fucoxanthin. Heme oxygenase-1 mRNA expression after CCl 4 injection was higher in the CCl 4 +fucoxanthin group than in the CCl 4 group, although the difference was not significant. The findings suggest that fucoxanthin attenuates hepatocyte apoptosis through heme oxygenase-1 induction in CCl 4 -induced acute liver injury.
INTRODUCTION
Fucoxanthin is a marine carotenoid found in wakame (undaria pinnatifida) and Hijiki (Hijikia fusiformis) and has certain remarkable biological properties, including antioxidant activity (Miyashita, 2009; Kim et al., 2010) , an anti-inflammatory effect (Sakai et al., 2009) , an anti-carcinogenic effect (Hosokawa et al., 2004; Kotake-Nara et al., 2005; Yu et al., 2011) and even utility as an anti-obesity agent (Maeda et al., 2005; Abidov et al., 2010) . The major structural difference between fucoxanthin and the other carotenoids is the presence of an unusual allenic bond, and this bond was shown to be responsible for the higher antioxidant activity of fucoxanthin (Dembitsky and Maoka, 2007; Sachindra et al., 2007) . The difference, however is that fucoxanthin acts as an antioxidant under hypoxic conditions, whereas other carotenoids have practically no quenching abilities. Under hypoxic conditions, fucoxanthin equimolarly reacted with 1,1-diphenyl-2-picrylhydrazyl (DPPH) as a radical quencher, whereas other carotenoids scarcely reacted with DPPH (Nomura et al., 1997) . As most tissues under physiological conditions have a low oxygen presence, fucoxanthin is suggested to have clinical potential as a therapeutic carotenoid for reactive oxygen species (ROS)-associated disorders (D'Orazio et al., 2012; Abidov et al., 2010) . It is worth mentioning that fucoxanthin also contains an α, β-unsaturated carbonyl group, and may function as a Michael acceptor which can react with important proteins such as Keap 1 in the nuclear factor E2-related factor-2 (Nrf2) system. A recent in vitro study showed that fucoxanthin enhanced heme oxygenase-1 (HO-1) and NAD(P)H dehydrogenase quinone 1 expression in murine hepatic BNL CL.2 cells through the activation of the Nrf2/ antioxidant response element (ARE) (Liu et al., 2011) .
Carbon tetrachloride (CCl 4 ) is a well-known chemical that is used for the induction of acute and chronic liver
The anti-apoptotic effect of fucoxanthin on carbon tetrachloride-induced hepatotoxicity injury characterized by pericentral and midzonal necrosis (Slater, 1966) . The trichloromethyl radical generated during the metabolism of CCl 4 interacts with oxygen to form the trichloromethyl peroxy radical, a highly reactive species. Trichloromethyl and its peroxy radical are capable of binding to proteins and lipids, or of abstracting a hydrogen atom from an unsaturated lipid, initiating lipid peroxidation and liver damage (Wong et al., 1995; Manibusan et al., 2007) . It is well known that oxygen partial pressure can direct the course of CCl 4 hepatotoxicity, and the location of CCl 4 -induced damage mirrors the oxygen gradient across the hepatic lobule (Ozaki and Masuda, 1993) . Cellular responses to toxin involve a number of defensive processes aimed at minimizing cell damage and redressing the balance of homeostasis, and the toxicity is commonly manifested in part as cellular apoptosis (Thomas et al., 2001) . Hepatocyte apoptosis is likely to play an important role in the development of CCl 4 -induced liver injury and sometimes either precedes the onset of necrosis or coexists with it (Herrera et al., 2001; Weber et al., 2003) . Therefore, understanding the mechanism of hepatocyte apoptosis is one of the primary goals related to the designing of future therapies for hepatic injury. The Keap1/ Nrf2/ARE signaling pathway has emerged as an important regulator of the mammalian defense system for the detoxification of agents such as CCl 4 , acetaminophen and furosemide, enabling adaptation to chemical and oxidative stress (Goldring et al., 2004; Lee and Johnson, 2004; Randle et al., 2008; Wen et al., 2006) . Under normal physiological conditions, Nrf2 resides in the cell cytoplasm where it associates with a repressor protein, Keap1 (Itoh et al., 1999) . Upon disruption of this interaction, Nrf2 is released and migrates to the nucleus where it binds to the ARE present in the promoter regions of many stress-activated genes, including HO-1 and the glutamate-cysteine ligase catalytic subunit (Weber et al., 2003) . This indicates that the cell is primed to respond to a chemical insult through rapid up-regulation of Nrf2-driven defensive proteins. As was mentioned above, fucoxanthin may participate in the Nrf2/ARE system and act as a radical quencher under hypoxia, so this xanthophyll is considered to have a potentially protective effect against CCl 4 -induced toxic liver injury. In this study, we investigated the anti-apoptotic effect of fucoxanthin on CCl 4 -induced hepatotoxicity using in vitro and in vivo models.
MATERIALS AND METHODS

Reagents
Chemicals: CCl 4 and fucoxanthin were purchased from the Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Solutions of CCl 4 were prepared in olive oil (1:3 v/v) before the experiments. Fucoxanthin was dissolved in a solution of 0.5% sodium carboxymethyl cellose, 0.5% Tween 80 and ultra pure water to obtain a final concentration of 0.5% (w/v). William's medium E and 10% fetal bovine serum (FBS) were obtained from Sigma Aldrich (St Louis, MO, USA). RIPA lysis buffer was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and the other chemicals and solvents were of analytical grade. Antibodies to HO-1 (rabbit polyclonal) and heat shock protein 25 (Hsp25) (rabbit polyclonal) were purchased from Stressgen Bioreagents (Ann Arbor, MI, USA) and Enzo Life Science (Farmingdale, NY, USA), respectively. Anti-rabbit IgG and anti-mouse IgG were from GE Healthcare (Buckinghamshire, UK).
Cell culture and experiments in vitro
Cell culture TRL1215 cell line was originally derived from the liver of a new-born Fisher 344 rat (Nagamine et al., 2008) and kindly donated by Prof. Waalkes (MP) (National Cancer Institute at NIEHS, USA). Hc cells (ACBRI 3716) were initiated from normal human liver tissues (Osawa et al., 2001) . These cells were cultured in William's medium E, supplemented with 10% FBS, 1 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. Cultures were maintained in a humidified atmosphere of 5% CO 2 at 37°C.
Cellular viability assay (MTT Assay) in TRL1215 cells
TRL1215 cells were plated at 1 × 10 3 cells cells per well in five 96-well tissue culture plates and grown in 10% FBS fortified media for 48 hr prior to treatment. Fucoxanthin was added directly to the culture medium of each plate to give a final concentration of 0, 0.5, 1, 10 or 25 μM. After 12 hr incubation, cells were exposed to various concentrations of CCl 4 ; 0, 0.1, 0.5, 1.0, 2.0 or 5 mM. The relative number of viable cells in each well was determined 20 hr after the administration of CCl 4 using a 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) assay according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). Briefly, 5 μl of MTT reagent was added to each well. After 4 hr incubation at 37°C, the media were removed and intracellular formazan products were lysed by the addition of 100 μl of dimethyl sulfoxide. The absorbance was recorded at 550 nm using a plate reader (MPRA4, Toso, Tokyo, Japan).
Immunohistochemistry of 
Animals and treatment procedures
Male Wistar rats (8 weeks of age) were purchased from CLEA Japan. Inc. (Tokyo, Japan). They were housed in the animal facility of Gunma University at a constant temperature and under a 12/12-hr light/dark cycle, and maintained on a standard CE-2 diet purchased from CLEA Japan. Inc. (Tokyo, Japan). The rats were acclimated for 1 week prior to use. All animal procedures were carried out in accordance with the guidelines for experiments using experimental animals at Gunma University.
After an over night fast, rats were randomly assigned to four experimental groups; control (olive oil) group (n = 3), fucoxanthin group (n = 3), CCl 4 group (n = 5) and CCl 4 +fucoxanthin group (n = 5). The fucoxanthin and CCl 4 +fucoxanthin groups were administered 50 mg/kg (B.W) of fucoxanthin by direct stomach intubation. Four hour later, the CCl 4 group and CCl 4 +fucoxanthin group were injected intraperitoneally with 0.25 ml/kg (B.W) of CCl 4 solution. The olive oil group received an equal volume of olive oil intraperitoneally. At 24 hr post-injection, the rats were anesthetized with ether and blood was collected from the jugular vein. The liver was surgically removed and a random sample from each lobe was fixed in 10% formalin, and then embedded in paraffin for hematoxylin-eosin (HE) staining and immunohistochemical staining. The remaining samples were kept frozen at -80°C until the biochemical and gene expression analyses.
Liver function tests along with fucoxanthin and fucoxanthinol levels
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in sera were measured using commercially available kits. The fucoxanthin and fucoxanthinol levels in sera were analyzed in two rats of the CCl 4 +fucoxanthin group and two rats of the olive oil group using a modified method reported previously (Asai et al., 2008; Hashimoto et al., 2009) . In brief, 500 μl of serum was mixed with 1.0 ml methanol and 2.0 ml dichloromethane, and the lower dichloromethane layer was collected. The serum was added 2.0 ml dichloromethane, then the lower layer was collected again. Both collected samples were used for assay. After evaporation, the residue from the dichloromethane layers was dissolved in 200 μl ethanol. The amounts of fucoxanthin and fucoxanthinol in the ethanol solution were measured by liquid chromatography/ mass/ mass spectroscopy (LC/MS/MS) using a HPLC system (1100 series, Agilent Technologies, Santa Clara, CA, USA) and a QTrap mass spectrometer (API-4000, Applied Biosystems, Foster City, CA, USA). HPLC was performed on a TSKgel ODS-100V column (150 × 2.0mm i.d., 3 μm, TOSOH Co. Ltd, Tokyo, Japan) at 30°C with acetonitrile/water (8:2) at a flow rate of 0.4 ml/min. The injection volume was 10 μl. MS/MS detection was carried out with an atmospheric pressure chemical ionization (APCI) source. The APCI source was set in negative ionization mode. Quantitation was performed using multiple reaction monitoring mode of the transitions of m/z 658 598 for fucoxanthin and m/z 616 558 for fucoxanthinol, respectively.
Liver pathology and immunohistochemistry
After deparaffinization, liver samples were cut into 4-μm sections and stained with hematoxylin-eosin. Two independent observers evaluated 5 optical fields (× 200 magnification) in each section chosen randomly under light microscopy, and counted the number of Councilman bodies per field. Then the mean number of Councilman bodies per section was calculated.
For immunohistochemistry, the sections were pretreated for 20 min with 3% hydrogen peroxide in PBS to quench any endogenous peroxidase activity. Then the sections were subjected to immunohistochemical staining using antibodies against HO-1or Hsp 25, as mentioned above.
Areas of positive staining were quantified with ImageJ 1.38 x software (Wayne Rasbans, NIH, Bethesda, USA). The ratios of the positively stained areas were calculated from the ratio of the positive staining (brown color by immunohistochemistry) to the whole area of the liver captured in digital images. Three ocular fields (× 400 magnification) per section were selected randomly from all of the samples, and the mean percentage of HO-1 positive cells per section was calculated. For the analysis of Hsp 25 positive cells, three ocular fields (× 200 magnifi-cation) per section were selected randomly, and the mean percentage of Hsp 25-positive cells was calculated.
TUNEL staining
Apoptotic bodies in the liver were detected by terminal deoxynucleotidyl -transferase (TdT)-mediated deoxyuridine triphosphate-digoxigenin (dUTP) nick-end labeling (TUNEL), which was performed using an In situ apoptosis detection kit (Roche Diagnostics). For analysis of the TUNEL-positive ratio, two independent observers evaluated 5 optical fields (× 400 magnification) for each specimen chosen randomly under light microscopy. Then the mean number of TUNEL-positive cells per specimen was calculated.
Metallothionein 1/2 values in liver tissues
Metallothionein (MT)1/2 values in liver tissues were assayed using the competitive ELISA according to the method described previously (Nakajima et al., 2010) . Briefly, 50 μl of sample specimen and 50 μl of MT antibody were added per well and incubated for 1 hr at 4°C in a microplate coated with rabbit MT2A. After incubation, wells were washed 3 times with PBS-T. Then, 100 μl of HRP conjugated anti-rabbit IgG goat antibody was added per well and incubated for 1 hr at room temperature. After incubation, wells were washed with PBS-T, and 100 μl of color substrate 3,3',5,5'-tetramethylbenzine were added and reacted for 10 min at room temperature. After the reaction, 50 μl of 1N H 2 SO 4 was added to stop the reaction. Optical density was read at a 450 nm wave-length by a plate reader (MPRA4, Toso, Tokyo, Japan)
Western blot analysis
Liver tissues were homogenized in 3X volume of RIPA lysis buffer and centrifuged at 10,000 × g for 15 min at 4°C, and the supernatant was recovered for the Western blotting of HO-1 and ß-actin. Proteins were separated using 12.5% SDS PAGE and transferred to PVDF membranes. Then the blotted membranes were blocked in Amersham ECL Prime Blocking Agent at 2% in T-PBS overnight at 4°C. After washing 3 times with PBS-T, the membranes were incubated for 1 hr at room temperature with an anti-HO-1 rabbit antibody (1:10,000) or anti-ß-actin mouse antibody (1:10,000). Subsequently, the membrane was washed with PBS-T and was stained for 1 hr at room temperature using peroxidase labeled anti-rabbit IgG (1:150,000) or anti-mouse IgG (1:75,000). After washing with PBS-T, the bound antibodies were visualized with the ECL-Prime Western Blotting Detection Reagent according to the manufacturer's protocol (GE Healthcare, Buckinghamshire, UK). Densitometry was used to measure the relative optical density of each specific band obtained after Western blotting.
Real time polymerase chain reaction (real time-PCR)
Quantitative real time-PCR was conducted in 10 μl reactions containing LightCycler 480 SYBR Green I Master (Roshe Applied Science, Indianapolis, IN, USA) using the LightCycler 480 (Roshe Applied Science, Indianapolis, IN, USA).
The oligonucleotide primers for HO-1, hypoxia inducible factor(HIF)-1α and GAPDH were as follows:
HO-1 Forward, 5'-CTGTGTAACCTCTGCTGTTCC -3' HO-1 Reverse, 5'-CCACACTACCTGAGTCTACC -3' HIF-1α Forward, 5'-TGCTCATCAGTTGCCACTT-3' HIF-1α Reverse, 5'-TGGGCCATTCTGTGTGTA-3' GAPDH Forward 5'-ATGGTGAAGGTCGGTGTGAAC GAPDH Reverse 5′-TGTAGTTGAGGTCAATGAAGG-3′ Reaction mixtures were incubated for an initial denaturation at 95°C for 10 sec, followed by 40 PCR cycles. Each cycle consisted of 95°C for 10 sec and 60°C for 10 sec, and 72°C for 10 sec, then 72°C for 10 min. The expression level of each mRNA was normalized by comparison with that of GAPDH. And samples were quantified using standard cDNA dilutions.
Statistical analysis
Data were analyzed with Dr SPSS II (SPSS, Chicago, IL, USA). The statistical significance of difference was determined with the Tukey-Kramer test and Games-Howell test after 1-way ANOVA. Probabilities of p < 0.05 were regarded as statistically significant.
RESULTS
MTT assay
Proliferation of TRL1215 cells was inhibited by CCl 4 in a dose-dependent manner (Fig. 1) . Pretreatment with more than 10 μM fucoxanthin attenuated the growth inhibition of TRL1215 cells by CCl 4 , while 0.5 and 1.0 μM of fucoxanthin did not ameliorate CCl 4 -hepatotoxicity. In the case of hepatotoxicity induced by 2 or 5 mM of CCl 4 , a high concentration of fucoxanthin (25 μM) markedly reduced the hepatotoxicity compared to 10 μM of fucoxanthin.
Immunohistochemistry in Hc cells and TRL1215 cells
HO-1 was clearly stained within the cytoplasm of Hc cells, and HO-1 expression was increased 24 hr after the administration of 5 μM fucoxanthin. In TRL1215 cell, the immunoreactivity of the HO-1 antibody was weak, and the intensity of the HO-1 stain was slightly increased by the administration of 5 μM fucoxanthin (Fig. 2) .
Liver function tests, and the fuxoanthin and fucoxanthinol levels in rats
The serum ALT levels (UI/l) in rats were significantly (p < 0.05) elevated in the CCl 4 +fucoxanthin group (211.8 ± 67.4) and the CCl 4 group (247.8 ± 47.6) compared to the olive oil group (40.0 ± 7.0). The serum AST levels (UI/l) were also significantly elevated in the CCl 4 +fucoxanthin group (444.0 ± 110.2) and the CCl 4 group (482.6 ± 21.7) compared to the olive oil group (91.3 ± 3.5). The CCl 4 +fucoxanthin group displayed lower ALT and AST levels than the CCl 4 group, although the difference was not significant. Fucoxanthin alone did not alter the ALT (37.3 ± 4.2) or AST levels (151.0 ± 61.4).
Fucoxanthin and its metabolite fucoxanthinol were detected in the sera of rats 28 hr after the oral administration of 10 mg fucoxanthin. The fucoxanthin levels (0.322 and 0.330 μg/ml) were higher than the fucoxanthinol levels (0.112 and 0.180 μg/ml). Neither fucoxanthin nor fucoxanthinol was detected in the sera of the olive oiltreated rats.
Liver pathology
CCl 4 -injected rat livers exhibited degenerative and/or necrotic hepatocytes concomitant with inflammatory cell infiltration and steatosis in the pericentral area. Hydrophic degeneration of the hepatocytes was observed around the apoptotic and/or necrotic hepatocytes . The lesions were similar in the CCl 4 and CCl 4 +fucoxantin groups. Councilman bodies, regarded as a sign of the apoptotic process (Kerr et al., 1979; Kanzler and Gall, 2000) , appeared sporadically around the central vein in the CCl 4 -injected liver (Fig. 3 top left) . The number of Councilman bodies was significantly (p < 0.05) reduced in the CCl 4 +fucoxanthin group compared with the CCl 4 group . No histological changes were found in the liver of the fucoxanthin group or the olive oil group (Fig. 3 top right) .
TUNEL staining
The TUNEL-positive nuclei of hepatocytes regarded as apoptotic cells were markedly increased in the pericentral area of the CCl 4 group, whereas TUNEL-positive cells were scarcely seen in the CCl 4 +fucoxanthin, fucoxanthin or olive oil group, respectively. The areas of the TUNEL-positive hepatocytes corresponded to the areas where Councilman bodies and/or degenerative hepatocytes were observed (Fig. 3 bottom left) . The number of the TUNEL-positive hepatocyte nuclei in the CCl 4 group was significantly (p < 0.01) higher than in the CCl 4 + fucoxantin group. However, there was no difference in the number of TUNEL-positive cells among the CCl 4 + fucoxantin, fucoxanthin and olive oil groups (Fig. 3 bottom  right) .
Immunohistochemistry of HO-1 in rat liver
HO-1 was stained mainly in Kupffer cells and sporadically in the nuclei of hepatocytes, and the number and intensity of the HO-1-positive cells were increased after CCl 4 injection. In the CCl 4 + fucoxanthin group, numerous Kupffer cells strongly reacted to HO-1, but HO-1-positive cells were rarely observed in the fucoxanthin group or the olive oil group (Fig. 4 top left) . The percentage of HO-1-positive cells was significantly higher in the CCl 4 + fucoxanthin group than the CCl 4 group (p < 0.05), the fucoxanthin group (p < 0.01) and the olive oil group (p < 0.05).
There was no significant difference in the percentage of HO-1-positive cells among the CCl 4 , fucoxanthin and olive oil groups (Fig. 4 top right) .
Western blotting of HO-1 in rat liver
The HO-1 protein was significantly (p < 0.05) increased in the CCl 4 + fucoxanthin group compared to the CCl 4 group, was similar between the CCl 4 group and the control (Fig. 4 bottom) .
Immunohistochemistry of Hsp25 in rat liver
The Hsp25 protein was stained in both the cytoplasm and nuclei of the hepatocytes in the pericentral area of the CCl 4 injected liver, an effect which was evidently reduced in rats with pretreatment of fucoxanthin compared to those without fucoxanthin. There was no staining of Hsp25 in hepatocytes of the fucoxanthin group or the olive oil group (Fig. 5 left) . The percentage of Hsp25-positive cells was significantly (p < 0.05) higher in the CCl 4 group than the CCl 4 +fucoxanthin group (Fig. 5 right) .
MT values in liver tissues
MT1/2 values in liver tissues were unchanged by CCL 4 injection, and. administration of fucoxanthin did not alter MT1/2 values in rat liver [MT1/2 values (μg/g): the CCl 4 + fucoxanthin group 27.1 ± 8.9, the CCl 4 group 25.7 ± 7.8, the fucoxanthin group 22.4 ± 3.1, the olive oil group 35.4 ± 10.1].
Real time RT-PCR
HO-1 mRNA was slightly increased 24 hr after CCl 4 injection. HO-1 mRNA expression was higher in the CCl 4 +fucoxanthin group than the CCl 4 group, although the difference was not significant. Hypoxia inducible factor (HIF)-1α mRNA expression was unchanged by CCl 4 with/or without fucoxanthin (Fig. 6) .
DISCUSSION
Since CCl 4 -induced liver injury is a commonly used model for the screening of the antihepatotoxic/hepatoprotective activities of drugs (Goldring et al., 2004; Lee and Johnson, 2004; Wen et al., 2006; Randle et al., 2008) , we examined the effect of fucoxanthin on CCl 4 -indeuced hepatotoxicity. In the present study, MTT assay clearly demonstrated that fucoxanthin attenuated CCl 4 -induced hepatotoxicity. This effect was dose-dependent; 25 μM of fucoxanthin was more effective than 10 μM for the hepatotoxicity induced by 2 or 5 mM of CCl 4 . On the other hand, low concentrations, such as 0.5 and 1.0 μM of fucoxanthin, did not attenuate CCl 4 -hepatotoxicity. In CCl 4 -injected rats, Councilman bodies, known as sign of the apoptotic process (Kerr et al., 1979; Kanzler and Gall, 2000) , and apoptotic hepatocytes positive for TUNEL staining, were markedly evident in the centrilobular zone 3 area of the liver. No councilman bodies and few hepatocytes undergoing apoptosis were found in the liver specimens of the fucoxanthin and olive oil groups. This result confirmed the findings of previous studies (Irie et al., 2010; Srilaxmi et al., 2010) , in which apoptotic hepatocytes were seen in zone 3 after the injection of a single dose of CCl 4 . The present study clearly showed that pretreatment of CCl 4 -injected rats with fucoxanthin significantly (p < 0.05) reduced the presence of Councilman bodies and hepatocyte apoptosis. Hepatocyte apoptosis in the CCl 4 +fucoxanthin group was attenuated to an extent close to the olive oil group. In other words, CCl 4 -induced hepatocyte apoptosis was apparently prevented by pretreatment with fucoxanthin, suggesting that fucoxanthin has an anti-apoptotic effect and inhibited the toxic damage. There have been a number of reports on the anticancer properties of fucoxanthin through apoptosis induction (Hosokawa et al., 2004; Kotake-Nara et al., 2005; Yu et al., 2011) , while the anti-apoptotic effect of fucoxanthin was reported in only a single in vitro study (Heo and Jeon, 2009) . This is the first study to demonstrate the antiapoptotic effect of fucoxanthin in vivo.
The anti-apoptotic mechanism of the effect of fucoxanthin on CCl 4 -induced acute hepatotoxicity remains to be elucidated; however, HO-1 induction by fucoxanthin has attracted interest in terms of protection against CCl 4 -induced hepatotoxicity. The HO-1 induced by CCl 4 degrades heme to carbon monoxide, which possesses anti-inflammatory, anti-proliferative and anti-apoptotic activities (Farombi and Surh, 2006) . Indeed, overexpression of HO-1 with glycyrrhizin alleviates CCl 4 -induced acute liver injury in mice (Lee et al., 2007) . The present in vitro study revealed that 5 μM of fucoxanthin increased HO-1 expression in both Hc cells and TRL1215 cells. In the rat liver 24 hr after CCl 4 injection, HO-1 was markedly expressed, principally in Kupffer cells and sporadically in the nuclei of hepatocytes. The ratio of HO-1-positive cells significantly (p < 0.05) higher in rats treated with CCl 4 and fucoxanthin than with CCl 4 alone. In addition, pretreatment with fucoxanthin significantly (p < 0.05) increased the hepatic HO-1 protein content in CCl 4 -injected rats. HO-1 mRNA expression was up-regulated in the following order, the CCl 4 +fucoxanthin group, the CCl 4 group, the olive oil group and the fucoxanthin group, although the difference between the groups was not significant. This result is similar to one reported by Liu et al. (2011) , in which fucoxanthin significantly increased HO-1 protein expression, but mildly up-regulated HO-1 mRNA in murine hepatic BNL CL.2 cells after incubation for 24 hr. Sass et al. (2003) showed that up-regulation of endogenous HO-1 rescued mice from the apoptotic liver damage induced by anti-CD3Ab, lipopolysaccharide or tumor necrosis factor-α. When these data are taken into consideration together with our in vivo and in vitro findings, it is suggested that fucoxanthin exerts an anti-apoptotic effect on CCl 4 -induced apoptotic hepatocytes via HO-1 induction. The Keap1-Nrf2-ARE signaling pathway has emerged as an important regulator in the mammalian detoxication of CCl 4 through the up-regulation of the cellular antioxidant enzyme HO-1 (Randle et al., 2008) . HO-1 induction . HO-1 and HIF-1α mRNA expression in rat liver. HO-1 mRNA expression in the liver was measured by real time PCR analysis, and samples were quantified using standard cDNA dilutions. HO-1 mRNA expression is higher in the CCl 4 + fucoxanthin group than the CCl 4 group, the fucoxanthin group and the olive oil group, although the difference is not significant. HIF-1α mRNA expression was unchanged by CCl 4 with/or without fucoxanthin. The results are presented as the mean ± S.D.
by fucoxanthin is mediated through several pathways. HO-1 induction by fucoxanthin was previously evaluated in detail using liver BNL CL.2 cells (Liu et al., 2011) , with the result that fucoxanthin significantly increased the phosphorylation of ERK and p38 and markedly increased nuclear Nrf2 protein accumulation. Moreover, fucoxanthin was shown to significantly enhance the binding activities of nuclear Nrf2 with ARE, and to increase the mRNA and protein expression of HO-1. Furthermore, siRNA inhibition of Nrf2 led to markedly decreased HO-1 protein expression. However, there has been no reported study in vivo on HO-1 induction by fucoxanthin. An in vivo study is necessary to elucidate whether the oral administration of fucoxanthin is absorbed via the intestinal tract. Sugawara et al. (2002) showed that dietary fucoxanthin was deacetylated into fucoxanthinol in the intestinal tract and incorporated as fucoxanthinol into the blood circulation system. A similar metabolic pathway of fucoxanthin was also reported in rats (Sangeetha et al., 2010) . The present study detected fucoxanthin and its metabolite of fucoxanthinol in the sera of rats collected 28 hr after oral administration of fucoxanthin, indicating that fucoxanthin, at least partly, was able to be absorbed through the intestinal tract in rats. Since fucoxanthin enhances HO-1 induction in the rat liver, fucoxanthin may exert its antioxidant activity through an activation of the Nrf2/ARE system, as was reported in the cultured hepatocytes (Liu et al., 2011) . Hsp function as molecular chaperones in regulating cellular homeostasis and promoting cell survival (Ellis, 2007) . Many studies have demonstrated that Hsp-induced cytoprotection can be attributed in part to the suppression of apoptosis (Concannon et al., 2001) . Hsp25 is one of the major classes of Hsp families in the rat and mouse, a homolog for human Hsp27, and the inhibitory effect of Hsp25 on the apoptosis pathway is well known (Salminen et al., 1997; Sreedhar et al., 2004) . More recently, the induction of the Hsp25 protein and apoptotic cells were reported in the pericentral area of rat liver after CCl 4 injection (Fujisawa et al., 2012) . In line with this report, the present study showed that apoptotic cells, demonstrable by the TUNEL method, were obviously seen in the pericentral area, corresponding to the area where Hsp25 was expressed. However, the marked induction of Hsp25 by CCl 4 in rat liver was significantly (p < 0.05) decreased by pretreatment with fucoxanthin, and fucoxanthin alone did not induce Hsp25 expression immunohistochemically. Thus, the anti-apoptotic effect of fucoxanthin is unlikely to be due to Hsp25 induction. Since fucoxanthin acts as an antioxidant under hypoxic conditions (Nomura et al., 1997) , we have also investigated hypoxia inducible factor (HIF)-1α and metallothionein (MT)1/2 expression, critical hypoxia-induced proteins (Murphy et al., 2008; Adams et al., 2009) , in the resent study. Consequently, it was also shown that HIF-1α and MT1/2 did not participate in the anti-apoptotic effect of fucoxanthin on CCl 4 -hepatotoxicity .
Hepatocyte apoptosis sometimes precedes the onset of necrosis, or coexists with it, therefore a drug which affords protection against hepatocyte apoptosis also protects against the secondary necrosis of liver tissue (Herrera et al., 2001; Weber et al., 2003) . In the present study, the serum AST and ALT levels were lower in the CCl 4 +fucoxanthin group than the CCl 4 group, but the difference was not significant, despite a marked suppression for hepatocytes apoptosis. The reason is speculated to be that fucoxanthin markedly suppresses apoptosis but mildly attenuates necrosis in hepatocytes subjected to CCl 4 toxicity.
In conclusion, fucoxanthin, via the induction of HO-1, decisively reduces hepatocyte apoptosis induced by CCl 4 . Clarification of the anti-apoptotic pathway mediated by fucoxanthin will require future study. There is increasing evidence that HO-1 is protective in several disparate models of hepatic stress. As the induction of HO-1 expression by fucoxanthin if of potential therapeutic value, further experiments using well designed in vivo models to properly evaluate the efficacy of fucoxanthin are warranted.
